Providers who stay informed about regulatory updates, insurance trends, and patient education needs will be better positioned to navigate this evolving treatment environment
And unlike manufacturer DTC programs, Kongo offers optional lab testing to help monitor your health throughout treatmentadding a layer of clinical oversight many alternatives dont provide
theoretical risks include increased hypoglycaemia, unpredictable cardiovascular effects, and compounded uncertainty from two incompletely characterised compounds
Not a rubber-stamp questionnaire, but genuine review of your health and history
Dosing frequency GLP-1s vary in their dosing frequency, which can significantly impact patient adherence and preference: Twice-daily: Exenatide (Byetta) Once-daily: Liraglutide (Victoza, Saxenda), Semaglutide tablets (Rybelsus) Once-weekly: Semaglutide (Ozempic, Wegovy), Dulaglutide (Trulicity), Exenatide extended-release (Bydureon), Tirzepatide (Mounjaro, Zepbound) The once-weekly formulations generally offer greater convenience and may improve adherence